Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 0 Breast Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00769379
What this trial is testing

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

Who this might be right for
Breast Ductal Carcinoma In Situ
National Cancer Institute (NCI) 2,014
Not applicableStudy completedNCT03319342
What this trial is testing

Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors

Who this might be right for
Cancer SurvivorStage 0 Breast Cancer AJCC v6 and v7Stage I Breast Cancer AJCC v7+6 more
Jonsson Comprehensive Cancer Center 133
Large-scale testing (Phase 3)Study completedNCT00003771
What this trial is testing

Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer

Who this might be right for
Breast CancerMenopausal Symptoms
Regional Oncologic Center 1,300
Not applicableStudy completedNCT03669952
What this trial is testing

Study of the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast Cancer

Who this might be right for
Outcome of Breast Cancer
Omphis Foundation 464
Not applicableStudy completedNCT03430765
What this trial is testing

Preventing Persistent Pain and Reducing Depressive and Anxious Symptoms Following Mastectomy and Lumpectomy

Who this might be right for
Persistent Postsurgical PainBreast Cancer FemaleDuctal Carcinoma in Situ
Katherine Hadlandsmyth 62
Not applicableStudy completedNCT00945061
What this trial is testing

Radiation Therapy in Treating Patients With Recurrent Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 13
Not applicableStudy completedNCT00445445
What this trial is testing

Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 2,201
Large-scale testing (Phase 3)Active Not RecruitingNCT01349322
What this trial is testing

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

Who this might be right for
Breast Cancer
Radiation Therapy Oncology Group 2,354
Testing effectiveness (Phase 2)Looking for participantsNCT06540872
What this trial is testing

Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer

Who this might be right for
Carcinoma, Intraductal, Noninfiltrating
Universität Münster 30
Not applicableStudy completedNCT01841749
What this trial is testing

Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast

Who this might be right for
Intraductal Carcinoma and Lobular Carcinoma in Situ
Institut Bergonié 228
Early research (Phase 1)Study completedNCT04693338
What this trial is testing

Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+1 more
Mayo Clinic 100
Very early researchEnded earlyNCT01479348
What this trial is testing

Imaging Study for FdCyd and THU Cancer Treatment

Who this might be right for
Head and Neck NeoplasmsLung NeoplasmsUrinary Bladder Neoplasms+1 more
National Cancer Institute (NCI) 5
Large-scale testing (Phase 3)Study completedNCT00590785
What this trial is testing

Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)

Who this might be right for
High RiskBreast CancerPositive Nodes+2 more
National Cancer Institute (NCI) 60
Not applicableStudy completedNCT01874184
What this trial is testing

Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaAtypical Lobular Breast HyperplasiaBRCA1 Mutation Carrier+3 more
University of Washington 17
Testing effectiveness (Phase 2)Ended earlyNCT00082667
What this trial is testing

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 1
Not applicableStudy completedNCT00081965
What this trial is testing

Acupuncture in Treating Hot Flashes in Women With Breast Cancer

Who this might be right for
Breast CancerHot Flashes
Memorial Sloan Kettering Cancer Center 80
Not applicableLooking for participantsNCT07711847
What this trial is testing

Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy

Who this might be right for
Invasive Breast Cancer Early StagesDuctal Carcinoma In Situ, DCIS
HeroSupport SA 30
Not applicableLooking for participantsNCT07095114
What this trial is testing

Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.

Who this might be right for
Ductal Carcinoma in SituStage I Breast CancerStage II Breast Cancer+1 more
Barbara Ann Karmanos Cancer Institute 30
Not applicableActive Not RecruitingNCT02240836
What this trial is testing

Energy Balance and Breast Cancer Aspects-II

Who this might be right for
DCIS Grade 3Stage I Breast CancerStage II Breast Cancer+1 more
Oslo University Hospital 545
Not applicableStudy completedNCT05810025
What this trial is testing

FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments

Who this might be right for
Breast Cancer
Columbia University 70
Next Page